← Leaderboards
Andrew P Lieberman
University Of Michigan At Ann Arbor
$22,338,719
Attributed
$25,997,693
Total exposure
18
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,997,693 · 18
By mechanism
R01$16,016,217 · 4
P30$2,612,614 · 2
T32$2,565,064 · 2
R21$1,574,685 · 3
P50$1,035,613 · 1
R33$770,215 · 1
Top collaborators
- Zaneta Nikolovska-Coleska10 shared
- Yoichi Osawa8 shared
- Daniel Ryland Southworth5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jason E Gestwicki$15,909,306
- Yoichi Osawa$10,706,601
- Joel M. Weinberg$3,828,236
- Jason Paul Chua$667,368
- Daniel Ryland Southworth$8,878,677
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisNerve DegenerationProteinsToxic EffectPathway InteractionsLaboratoriesBasePhenotypeCellsBiochemicalMutantNeuropathologyGeneticMouse ModelNeuronsAndrogen ReceptorAllelesLeadImpairmentNovel Therapeutic InterventionAffectTherapeutic TargetDisease-Causing MutationNeuron Loss
Grant awards (83)
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration$563,089
R01 · FY2025 · NS · contact PI
Mechanisms of neuromuscular degeneration in SBMA$498,416
R01 · FY2025 · NS · contact PI
Training Program in Translational Research$321,270
T32 · FY2025 · GM · contact PI
Core D: Neuropathology Core$266,916
P30 · FY2025 · AG · contact PI
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration$546,195
R01 · FY2024 · NS · contact PI
Mechanisms of neuromuscular degeneration in SBMA$489,082
R01 · FY2024 · NS · contact PI
Training Program in Translational Research$329,616
T32 · FY2024 · GM · contact PI
Core D: Neuropathology Core$263,076
P30 · FY2024 · AG · contact PI
Mechanisms of neuromuscular degeneration in SBMA$599,008
R01 · FY2023 · NS · contact PI
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration$563,089
R01 · FY2023 · NS · contact PI
Training Program in Translational Research$318,321
T32 · FY2023 · GM · contact PI
Core D: Neuropathology Core$248,076
P30 · FY2023 · AG · contact PI
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration$77,532
R01 · FY2023 · NS · contact PI
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration$563,089
R01 · FY2022 · NS · contact PI
Mechanisms of neuromuscular degeneration in SBMA$538,165
R01 · FY2022 · NS · contact PI
Training Program in Translational Research$312,217
T32 · FY2022 · GM · contact PI
Core D: Neuropathology Core$248,076
P30 · FY2022 · AG · contact PI
Therapeutic targets for Niemann-Pick type C neurodegeneration$78,690
R01 · FY2022 · NS · contact PI
Therapeutic targets for Niemann-Pick type C neurodegeneration$563,089
R01 · FY2021 · NS · contact PI
Mechanisms of neuromuscular degeneration in SBMA$551,035
R01 · FY2021 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$512,581
R01 · FY2021 · NS · contact PI
Training Program in Translational Research$292,577
T32 · FY2021 · GM · contact PI
Core D: Neuropathology Core$248,076
P30 · FY2021 · AG · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$523,094
R01 · FY2020 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$396,149
R01 · FY2020 · NS · contact PI
Small molecule stabilizers of Hsp70 for treatment of spinal and bulbar muscular atrophy$381,139
R33 · FY2020 · NS · contact PI
Core D: Neuropathology Core$303,117
P30 · FY2020 · AG · contact PI
Training Program in Translational Research$241,028
T32 · FY2020 · GM · contact PI
A mouse model Niemann-Pick type C disease to test proteostasis therapies$148,533
R03 · FY2020 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$538,742
R01 · FY2019 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$396,149
R01 · FY2019 · NS · contact PI
Small molecule stabilizers of Hsp70 for treatment of spinal and bulbar muscular atrophy$389,076
R33 · FY2019 · NS · contact PI
Core D: Neuropathology Core$249,699
P30 · FY2019 · AG · contact PI
Training Program in Translational Research$190,645
T32 · FY2019 · GM · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$532,999
R01 · FY2018 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$396,149
R01 · FY2018 · NS · contact PI
Small molecule stabilizers of Hsp70 for treatment of spinal and bulbar muscular atrophy$388,542
R21 · FY2018 · NS · contact PI
Core D: Neuropathology Core$255,324
P30 · FY2018 · AG · contact PI
Training Program in Translational Research$188,520
T32 · FY2018 · GM · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$588,180
R01 · FY2017 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$396,149
R01 · FY2017 · NS · contact PI
Core D: Neuropathology Core$281,081
P30 · FY2017 · AG · contact PI
Training Program in Translational Research$186,446
T32 · FY2017 · GM · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$396,149
R01 · FY2016 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$340,156
R01 · FY2016 · NS · contact PI
Core D: Neuropathology Core$249,173
P30 · FY2016 · AG · contact PI
Training Program in Translational Research$184,424
T32 · FY2016 · GM · contact PI
Antisense oligonucleotides to treat spinal and bulbar muscular atrophy$387,500
R21 · FY2015 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$340,156
R01 · FY2015 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$334,041
R01 · FY2015 · NS · contact PI
Antisense oligonucleotides to treat spinal and bulbar muscular atrophy$388,542
R21 · FY2014 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$336,755
R01 · FY2014 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$330,818
R01 · FY2014 · NS · contact PI
Androgen Receptor SUMOylation in SBMA$77,750
R03 · FY2014 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$328,251
R01 · FY2013 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$322,579
R01 · FY2013 · NS · contact PI
Targeting proteostasis to treat Niemann-Pick C disease$182,307
R21 · FY2013 · NS · contact PI
Androgen Receptor SUMOylation in SBMA$77,750
R03 · FY2013 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy disease$340,156
R01 · FY2012 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$334,394
R01 · FY2012 · NS · contact PI
Targeting proteostasis to treat Niemann-Pick C disease$227,794
R21 · FY2012 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$341,384
R01 · FY2011 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$334,506
R01 · FY2011 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$358,652
R01 · FY2010 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$316,022
R01 · FY2010 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$58,272
R01 · FY2010 · NS · contact PI
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse models$359,456
R01 · FY2009 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$319,214
R01 · FY2009 · NS · contact PI
CORE--NEUROPATHOLOGY CORE$257,121
P50 · FY2009 · AG · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$6,750
R01 · FY2009 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$319,214
R01 · FY2008 · NS · contact PI
CORE--NEUROPATHOLOGY CORE$250,626
P50 · FY2008 · AG · contact PI
A conditional null mutant of the mouse Npc1 gene$72,204
R03 · FY2008 · NS · contact PI
Mechanisms of motor neuron toxicity in Kennedy Disease$288,621
R01 · FY2007 · NS · contact PI
CORE--NEUROPATHOLOGY CORE$248,565
P50 · FY2007 · AG · contact PI
A conditional null mutant of the mouse Npc1 gene$72,204
R03 · FY2007 · NS · contact PI
Modifiers of Polyglutamine Toxicity$208,000
K08 · FY2006 · AG · contact PI
CORE--NEUROPATHOLOGY CORE$141,714
P50 · FY2006 · AG · contact PI
Modifiers of Polyglutamine Toxicity$208,000
K08 · FY2005 · AG
CORE--NEUROPATHOLOGY CORE$137,587
P50 · FY2005 · AG
Modifiers of Polyglutamine Toxicity$208,000
K08 · FY2004 · AG
Altered Androgen Receptor Function Due to CAG Expansion$175,422
K02 · FY2003 · NS
Altered Androgen Receptor Function Due to CAG Expansion$175,422
K02 · FY2002 · NS